Trial Profile
Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia in France and Its Use in Routine Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PILOTE
- Sponsors Amgen
- 03 Oct 2018 Status changed from active, no longer recruiting to completed.
- 18 Jul 2018 Planned End Date changed from 20 Jul 2018 to 30 Sep 2018.
- 17 Oct 2017 Planned primary completion date changed from 1 Mar 2017 to 11 Dec 2017.